Role of Calcium Homeostasis in Modulating EMT in Cancer

por Jones, Clark A., Hazlehurst, Lori A.
Publicado 2021

The Role of TRPC1 in Modulating Cancer Progression

por Elzamzamy, Osama M, Penner, Reinhold, Hazlehurst, Lori A
Publicado 2020

Role of STAT3 in Transformation and Drug Resistance in CML

por Nair, Rajesh R., Tolentino, Joel H., Hazlehurst, Lori A.
Publicado 2012

The Role of ERO1α in Modulating Cancer Progression and Immune Escape

por Johnson, Brennan D., Geldenhuys, Werner J., Hazlehurst, Lori A.
Publicado 2020

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab

por Chen, Wei-Chih, Kanate, Abraham S, Craig, Michael, Petros, William P, Hazlehurst, Lori A
Publicado 2017

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

por Wang, Lei, Yi, Weijun, Ma, Li, Lecea, Emily, Hazlehurst, Lori A., Adjeroh, Donald A., Hu, Gangqing
Publicado 2023

Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma

por Elzamzamy, Osama M., Johnson, Brandon E., Chen, Wei-Chih, Hu, Gangqing, Penner, Reinhold, Hazlehurst, Lori A.
Publicado 2021

Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines

por Jones, Clark, Dziadowicz, Sebastian, Suite, Samuel, Eby, Ashley, Chen, Wei-Chih, Hu, Gangqing, Hazlehurst, Lori A.
Publicado 2022

Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment

por Shay, Gemma, Tauro, Marilena, Loiodice, Fulvio, Tortorella, Paolo, Sullivan, Daniel M., Hazlehurst, Lori A., Lynch, Conor C.
Publicado 2017

Identification of Natural Product Sulfuretin Derivatives as Inhibitors for the Endoplasmic Reticulum Redox Protein ERO1α

por Johnson, Brennan D., Kaulagari, Sridhar Reddy, Chen, Wei-Chih, Hayes, Karen, Geldenhuys, Werner J., Hazlehurst, Lori A.
Publicado 2022

MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma

por Emmons, Michael F., Anreddy, Nagaraju, Cuevas, Javier, Steinberger, Kayla, Yang, Shengyu, McLaughlin, Mark, Silva, Ariosto, Hazlehurst, Lori A.
Publicado 2017

Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma

por Dziadowicz, Sebastian A., Wang, Lei, Akhter, Halima, Aesoph, Drake, Sharma, Tulika, Adjeroh, Donald A., Hazlehurst, Lori A., Hu, Gangqing
Publicado 2022

CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo

por Turner, Joel G., Dawson, Jana, Emmons, Michael F., Cubitt, Christopher L., Kauffman, Michael, Shacham, Sharon, Hazlehurst, Lori A., Sullivan, Daniel M.
Publicado 2013

Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand

por Geldenhuys, Werner J., Long, Timothy E., Saralkar, Pushkar, Iwasaki, Toshio, Nuñez, Raisa A.A., Nair, Rajesh R., Konkle, Mary E., Menze, Michael A., Pinti, Mark V., Hollander, John M., Hazlehurst, Lori A., Robart, Aaron R.
Publicado 2019

Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β‐hairpin‐like scaffold, MTI‐101

por Jain, Priyesh, Badger, David B., Liang, Yi, Gebhard, Anthony W., Santiago, Daniel, Murray, Philip, Kaulagari, Sridhar R., Gauthier, Ted J., Nair, Rajesh, Kumar, MohanRaja, Guida, Wayne C., Hazlehurst, Lori A., McLaughlin, Mark L.
Publicado 2020